Belite Bio (BLTE) Change in Accured Expenses (2022 - 2025)

Belite Bio's Change in Accured Expenses history runs 4 years deep, the most recent figure standing at $1.8 million for Q4 2025.

• In Q4 2025, Change in Accured Expenses fell 36.71% year-over-year to $1.8 million; the TTM figure through Sep 2025 stood at $7.8 million (changed N/A YoY), while the FY2025 annual figure was $3.8 million, down 33.24% from the prior year.
• Change in Accured Expenses was $1.8 million for Q4 2025 at Belite Bio, down from $7.8 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $7.8 million in Q3 2025 to a low of $1.8 million in Q4 2025.
• Historically, Change in Accured Expenses has averaged $3.6 million across 4 years, with a median of $2.9 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses soared 74.45% in 2023, then sank 36.71% in 2025.
• A 4-year view of Change in Accured Expenses shows it stood at $1.9 million in 2022, then jumped by 74.45% to $3.3 million in 2023, then retreated by 12.51% to $2.9 million in 2024, then tumbled by 36.71% to $1.8 million in 2025.
• The last three Change in Accured Expenses figures came in at $1.8 million (Q4 2025), $7.8 million (Q3 2025), and $2.9 million (Q4 2024), per Business Quant data.